Banca de DEFESA: ADRIANA AMORIM DE FARIAS LEAL

Uma banca de DEFESA de DOUTORADO foi cadastrada pelo programa.
STUDENT : ADRIANA AMORIM DE FARIAS LEAL
DATE: 21/12/2022
TIME: 08:30
LOCAL: Remoto
TITLE:

ACCESS TO MEDICINES BY THE BRAZILIAN POPULATION: DATA FROM THE 2019 NATIONAL HEALTH SURVEY

KEY WORDS:

Access to essential medicines; Health Services Accessibility; Chronic Disease; Health Surveys; Brazil

PAGES: 125
BIG AREA: Ciências da Saúde
AREA: Saúde Coletiva
SUMMARY:

Introduction: Access to medication is a global challenge, especially in developing countries, so data from population surveys are essential to measure related factors. In addition, the high prevalence of people with chronic diseases and, consequently, who use continuous medication implies the need to guarantee this access through efficient public policies. Objective: To analyze access to medicines in Brazil and associated factors, based on data from the 2019 National Health Survey (PNS). Methods: This is a cross-sectional population-based study that used data from the PNS 2019, enabling the writing of three studies: 1 – general assessment of access to medicines by the Brazilian population, based on Andersen's behavioral model; 2 – analysis of factors associated with access to medication for the treatment of arterial hypertension and diabetes; 3 – study of factors associated with the use of medication for the treatment of depression. In the three studies, descriptive analysis was performed, followed by multivariate analysis, considering the independent variables that presented a significance level greater than 95%. Results: In article 1, it was observed that the greatest chances of not having access to medication at the individual level were observed in people aged between 40 and 59 years, women, people with complete elementary school and high school, with lower family income people who performed consultations in public services, individuals with a worse self-rated health and those who sought the health service for disease prevention and health promotion. In article 2, data regarding access via the Popular Pharmacy Program of Brazil (PFPB) and public service were analyzed. There was a higher prevalence of access to medication for hypertension and oral medication for diabetes via PFPB, and the factors that most influenced this access were a higher age group, lower income, lower education, not having a health plan and reporting a self-assessment of health too bad. Access to insulin, in turn, was more prevalent via the public health service, and the factors that most influenced this access were black/brown race, lower income, not having a health plan and reporting a very poor self-rated health. In article 3, it was found that the factors associated with not using medication prescribed for depression in the last two weeks were marital status, self-rated health, prevalence of sleep problems, routine medical appointments, and time since diagnosis of the disease. Conclusions: Access to medication in the Brazilian population is related to socioeconomic and health perception factors. In general, the importance of the PFPB as a policy to expand access to essential medicines in Brazil is proven, considering the free use of antihypertensive and antidiabetic drugs, as well as the weaknesses of the public health system in Brazil in the supply of medicines. Furthermore, these findings can guide the updating or formulation of public policies on medicines and pharmaceutical assistance, promoting better mechanisms for the purchase of medicines by the user and, consequently, reducing health inequities.

COMMITTEE MEMBERS:
Presidente - 1149540 - ANGELO GIUSEPPE RONCALLI DA COSTA OLIVEIRA
Interna - 2305247 - ISABELLE RIBEIRO BARBOSA MIRABAL
Interna - 421717 - MARIA ANGELA FERNANDES FERREIRA
Externo à Instituição - DANIELLE FRANKLIN DE CARVALHO - UEPB
Externa à Instituição - GABRIELA MARIA CAVALCANTI COSTA - UEPB